157 related articles for article (PubMed ID: 10609614)
1. Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes.
Ohta R; Imai M; Fukuoka Y; Miwa T; Okada N; Okada H
Microbiol Immunol; 1999; 43(11):1045-56. PubMed ID: 10609614
[TBL] [Abstract][Full Text] [Related]
2. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.
Miwa T; Sun X; Ohta R; Okada N; Harris CL; Morgan BP; Song WC
Immunology; 2001 Oct; 104(2):207-14. PubMed ID: 11683961
[TBL] [Abstract][Full Text] [Related]
3. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
[TBL] [Abstract][Full Text] [Related]
4. Functional differences among multiple isoforms of guinea pig decay-accelerating factor.
Wang G; Nonaka M; He C; Okada N; Nakashima I; Okada H
J Immunol; 1998 Mar; 160(6):3014-22. PubMed ID: 9510206
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
6. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
Miwa T; Okada N; Okada H
Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional analysis of mouse decay accelerating factor (CD55).
Harris CL; Rushmere NK; Morgan BP
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):821-9. PubMed ID: 10417349
[TBL] [Abstract][Full Text] [Related]
8. Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.
Harris CL; Spiller OB; Morgan BP
Immunology; 2000 Aug; 100(4):462-70. PubMed ID: 10929073
[TBL] [Abstract][Full Text] [Related]
9. Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.
Ahmad SR; Lidington EA; Ohta R; Okada N; Robson MG; Davies KA; Leitges M; Harris CL; Haskard DO; Mason JC
Immunology; 2003 Oct; 110(2):258-68. PubMed ID: 14511240
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies.
Lin F; Fukuoka Y; Spicer A; Ohta R; Okada N; Harris CL; Emancipator SN; Medof ME
Immunology; 2001 Oct; 104(2):215-25. PubMed ID: 11683962
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of decay-accelerating factor isoforms in the digestive tract of guinea pig.
Mizoshita T; Joh T; Oshima T; Yamada T; Ohara H; Nomura T; Okada N; Itoh M
Life Sci; 2002 Jan; 70(8):867-76. PubMed ID: 11853224
[TBL] [Abstract][Full Text] [Related]
13. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.
Sun X; Funk CD; Deng C; Sahu A; Lambris JD; Song WC
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):628-33. PubMed ID: 9892684
[TBL] [Abstract][Full Text] [Related]
14. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).
Karnauchow TM; Tolson DL; Harrison BA; Altman E; Lublin DM; Dimock K
J Virol; 1996 Aug; 70(8):5143-52. PubMed ID: 8764022
[TBL] [Abstract][Full Text] [Related]
15. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
16. Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis.
Fukuta D; Miyagawa S; Yamada M; Matsunami K; Kurihara T; Shirasu A; Hattori H; Shirakura R
Xenotransplantation; 2003 Mar; 10(2):132-41. PubMed ID: 12588646
[TBL] [Abstract][Full Text] [Related]
17. Cell-surface expression of an amino-terminal fragment of apolipoprotein B increases lipoprotein lipase binding to cells.
Pang L; Sivaram P; Goldberg IJ
J Biol Chem; 1996 Aug; 271(32):19518-23. PubMed ID: 8702644
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
Qian YM; Haino M; Kelly K; Song WC
Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
[TBL] [Abstract][Full Text] [Related]
19. Structure/function studies of human decay-accelerating factor.
Brodbeck WG; Kuttner-Kondo L; Mold C; Medof ME
Immunology; 2000 Sep; 101(1):104-11. PubMed ID: 11012760
[TBL] [Abstract][Full Text] [Related]
20. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1.
Shenoy-Scaria AM; Kwong J; Fujita T; Olszowy MW; Shaw AS; Lublin DM
J Immunol; 1992 Dec; 149(11):3535-41. PubMed ID: 1385527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
